Wave Life Sciences Ltd. [WVE] stock is trading at $8.19, up 53.37%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The WVE shares have gain 43.43% over the last week, with a monthly amount glided 42.68%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Wave Life Sciences Ltd. [NASDAQ: WVE] stock has seen the most recent analyst activity on September 19, 2024, when B. Riley Securities initiated its Buy rating and assigned the stock a price target of $11. Previously, JP Morgan started tracking the stock with Overweight rating on September 09, 2024, and set its price target to $10. On May 15, 2024, Wells Fargo initiated with a Overweight rating and assigned a price target of $11 on the stock. Leerink Partners upgraded its rating to a Outperform and increased its price target to $12 on December 19, 2023. Raymond James initiated its recommendation with a Outperform and recommended $7 as its price target on July 05, 2023. Jefferies downgraded its rating to Hold for this stock on May 24, 2023, and downed its price target to $5.
Wave Life Sciences Ltd. [WVE] stock has fluctuated between $3.50 and $7.67 over the past year. Currently, Wall Street analysts expect the stock to reach $14 within the next 12 months. Wave Life Sciences Ltd. [NASDAQ: WVE] shares were valued at $8.19 at the most recent close of the market. An investor can expect a potential return of 70.94% based on the average WVE price forecast.
Analyzing the WVE fundamentals
Wave Life Sciences Ltd. [NASDAQ:WVE] reported sales of 110.50M for the trailing twelve months, which represents a drop of -10.92%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at -0.76%, Pretax Profit Margin comes in at -0.67%, and Net Profit Margin reading is -0.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -6.58 and Total Capital is -2.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 6.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.92 points at the first support level, and at 5.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.90, and for the 2nd resistance point, it is at 9.62.
Ratios To Look Out For
For context, Wave Life Sciences Ltd.’s Current Ratio is 0.99. In addition, the Quick Ratio stands at 0.99 and the Cash Ratio stands at 0.89. Considering the valuation of this stock, the price to sales ratio is 9.25.
Transactions by insiders
Recent insider trading involved BOLNO PAUL, President and CEO, that happened on Aug 21 ’24 when 48366.0 shares were sold. Officer, PAUL BOLNO completed a deal on Aug 21 ’24 to buy 48366.0 shares. Meanwhile, Chief Financial Officer Moran Kyle sold 15630.0 shares on Apr 03 ’24.
